General Information of the Compound
| Compound ID |
CP0311126
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-quinolin-8-ylthiophene-2-sulfonamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
AC1LH19W
AKOS001422726
BDBM50372518
CHEMBL257234
CU-00000000139-1
MCULE-3746564892
MolPort-003-066-216
N-(8-Quinolyl)-2-thiophenesulfonamide
N-(quinolin-8-yl)thiophene-2-sulfonamide
N-quinolin-8-ylthiophene-2-sulfonamide
NCGC00161717-01
Oprea1_700618
SCHEMBL7190921
SR-01000012975
SR-01000012975-1
Z115639124
ZINC353084
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H10N2O2S2
|
||||||||||||||||||
| Molecular Weight |
290.369
|
||||||||||||||||||
| Canonical SMILES |
O=S(=O)(Nc1cccc2cccnc12)c1cccs1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H10N2O2S2/c16-19(17,12-7-3-9-18-12)15-11-6-1-4-10-5-2-8-14-13(10)11/h1-9,15H
Show/Hide
|
||||||||||||||||||
| InChIKey |
CPSRVVXBTZFZPM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( N-(quinolin-8-yl)thiophene-2-sulfonamide )
| Drug Name | N-(quinolin-8-yl)thiophene-2-sulfonamide | ||
|---|---|---|---|